Drug CEO: Trump’s FDA focused on approving drugs, curing diseases
President Donald Trump promised in his plan for his first 100 days to cut red tape at the Food and Drug Administration and speed up the approval of life-saving drugs. The CEO of a Virginia-based pharmaceutical company spoke to One America’s Neil W. McCabe about how the FDA is different now from under the previous administration.